ILMN Illumina
- 104.280
- +3.230+3.20%
- 103.340
- -0.940-0.90%
Illumina News
Illumina Shares Are Trading Lower. The Company Announced It Will Present Its Research at the ASCO Annual Meeting.
Illumina Shares Are Trading Lower. The Company Announced It Will Present Its Research at the ASCO Annual Meeting.
Illumina To Present Latest Research At American Society Of Clinical Oncology Annual Meeting In Chicago, May 31–June 4
Illumina To Present Latest Research At American Society Of Clinical Oncology Annual Meeting In Chicago, May 31–June 4
Immena Releases 2023 Corporate Social Responsibility Report
SAN DIEGO, Calif., May 29, 2024/PRNewswire/ -- On May 28, 2024, Immena (NASDAQ: ILMN), a global leader in genetic sequencing and chip technology, released its fifth annual corporate social responsibility (CSR) report, which highlights the company's continued commitment to patients, communities, employees, and the planet in 2023 and progress in advancing the cause of human health. “At Immena, we are committed to improving human health through the power of genes.” Inmena CEO Jacob Thaysen said, “”
Illumina Drives Genomic Testing as Standard of Care in Oncology Through Collaborative Research Presented at ASCO
Studies presented represent key focus areas, including building evidence for clinical utility of comprehensive genomic profiling; overcoming market access barriers, and progressing the whole-genome ap
Deel Elects Francis DeSouza to Its Board of Directors
deSouza brings decades of experience leading global, innovation-driven companies, both as an entrepreneur and growing large, complex companiesSAN FRANCISCO--(BUSINESS WIRE)--Deel today announced the e
Integrated Biosciences Joins Illumina Ventures Labs to Design Novel Therapeutics Targeting the Transcriptome
Partnership combines Integrated Biosciences' pioneering research in AI/ML-enabled small molecule drug discovery and bulk and single cell sequencing offered through Illumina Ventures Labs Integrated Biosciences, a
Illumina (NASDAQ:ILMN) Investors Are Sitting on a Loss of 74% If They Invested Three Years Ago
As every investor would know, not every swing hits the sweet spot. But really bad investments should be rare. So spare a thought for the long term shareholders of Illumina, Inc. (NASDAQ:ILMN); the s
Illumina Releases 2023 Corporate Social Responsibility Report
SAN DIEGO, May 28, 2024 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today published its fifth annual Corporate Social Responsibility (
One Illumina Insider Raised Their Stake In The Previous Year
TD Cowen Maintains Illumina(ILMN.US) With Hold Rating, Maintains Target Price $140
TD Cowen analyst Daniel Brennan maintains $Illumina(ILMN.US)$ with a hold rating, and maintains the target price at $140.According to TipRanks data, the analyst has a success rate of 50.0% and a total
Leerink Partners Maintains Illumina(ILMN.US) With Buy Rating
Leerink Partners analyst Puneet Souda maintains $Illumina(ILMN.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 36.3% and a total average return of -10.7% over the
Guardant Stock Climbs As Cancer Test Strides Towards FDA Ok -- WSJ
By Peter Loftus Shares of Guardant Health were up 8% Friday morning after an advisory panel to the U.S. Food and Drug Administration endorsed the companys blood test to detect colorectal cancer. A s
Press Release: Anna Richo Joins Illumina's Board of Directors
Anna Richo joins Illumina's Board of Directors PR Newswire SAN DIEGO, May 20, 2024 Ms. Richo brings more than 30 years of global legal, compliance, and regulatory experience to Illumina's Board SA
Anna Richo Joins Illumina's Board of Directors
Ms. Richo brings more than 30 years of global legal, compliance, and regulatory experience to Illumina's BoardSAN DIEGO, May 20, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that
Most Attractive Short-term Overwriting Stocks for June Expiration - Goldman
Goldman Sachs analysts identified short-term overwriting opportunities in large-cap, high implied volatility stocks that do not have earnings events.
Daiwa Securities Adjusts Price Target on Illumina to $120 From $133
Illumina (ILMN) has an average rating of outperform and price targets ranging from $100 to $253, according to analysts polled by Capital IQ. Price: 115.26, Change: -0.32, Percent Change: -0.28
Illumina To Webcast Upcoming Investor Conference
SAN DIEGO, May 15, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:Bernstein's 40th Annual Strategic Decisi
10 Health Care Stocks With Whale Alerts In Today's Session
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Illumina, Inc. (ILMN) RBC Capital Markets Global Healthcare (Transcript)
Illumina, Inc. (ILMN) RBC Capital Markets Global Healthcare (Transcript)
TD Cowen Sticks to Its Hold Rating for Illumina (ILMN)
Analysis
Price Target
No Data
